Skip to content Skip to navigation menu


Part of LGC Biosearch Technologies

Lucigen Corporation has been working to improve people’s lives by providing quality products and services to life science and healthcare professionals. Now, as part of the Biosearch Technologies family, we are continuing and enhancing this mission. Read more about Biosearch Technologies brand update.

 Lucigen grew to manufacture and sell over 325 biomedical research products and services to customers worldwide, all under an ISO 13485 compliant quality system. Lucigen has been the exclusive supplier of the Epicentre brand products to scientists worldwide since 2017. Core competencies include enzyme and competent cell manufacture, next gen sequencing services and library preparation kits, to molecular diagnostics, applied, government and academic customers.


Learn more

Ordering made easy

Find out more about our online ordering capabilities.

A brief history of Lucigen

  • Founded in Wisconsin, USA, in 1998, Lucigen’s portfolio enables life-science professionals to perform their research and testing more efficiently and effectively.

  • In 2017, Lucigen became the sole supplier for over 130 Epicentre-branded enzymes and reagents including QuickExtract DNA Extraction Solution, EZ-Tn5 Transposase and other world class enzymes, DNA/RNA extraction/ purification kits and more.

Lucigen merges with Biosearch Technologies, the comprehensive genomics portfolio from LGC

  • LGC acquires Lucigen in 2018, strengthening its reagents offering to the genomics market
  • Lucigen is a leading developer, manufacturer and supplier of molecular biology enzymes, reagents and kits.
  • Lucigen has an extensive portfolio of life science products including NGS kits, enzymes, competent cells, and cloning systems, targeting fast growth applications in clinical diagnostics, drug discovery, synthetic biology and gene editing.
  • Lucigen has tremendous assets including its highly skilled and motivated workforce, enzyme and kit development capabilities, complemented by ISO-13485 manufacturing. Lucigen’s assets are highly complementary to LGC’s capabilities, aligning squarely with our strategy.